Bergen Comm Reg Blood Center FDA Inspection Record

FEI 2275064 · Inspections, Form 483s, warning letters and import refusals

Bergen Comm Reg Blood Center is an FDA-inspected facility (FEI 2275064) located in Montvale, NJ, US. RegDataLab tracks 8 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jul 10, 2026: No Action Indicated (NAI)
Inspections on record
8 (3 VAI, 5 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
45, latest Mar 13, 2024

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jul 10, 2026No Action Indicated (NAI)No citations listed
Jan 25, 2023No Action Indicated (NAI)No citations listed
Feb 4, 2019No Action Indicated (NAI)No citations listed
Mar 31, 2017No Action Indicated (NAI)No citations listed
Jul 19, 2016No Action Indicated (NAI)No citations listed
May 15, 2014Voluntary Action Indicated (VAI)Provisions to monitor lab test procedures & instruments (21 CFR 606.140(b))
Qualifications of responsible personnel (21 CFR 606.20(b))
Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))
Mar 14, 2012Voluntary Action Indicated (VAI)Concurrent documentation (21 CFR 606.160(a)(1))
Qualifications of responsible personnel (21 CFR 606.20(b))
Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))
Relate products to the donor (21 CFR 606.100(b)(4))
and 1 more
Sep 27, 2010Voluntary Action Indicated (VAI)Adverse Reaction - Investigations (21 CFR 606.170(a))
Donor suitability procedures not followed (21 CFR 640.3(a)(1))
Arm preparation (21 CFR 640.4(f))
Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))

Recalls

Showing the 10 most recent of 45 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 13, 2024Class IIB-0293-2024Red Blood Cells, Leukocytes Reduced
Blood Product, collected from a donor who was a resident of a malaria endemic area, was distributed.
Oct 7, 2022Class IIB-0383-2023PF24 Plasma
Blood product, where transfusion-transmitted infection testing was incorrectly documented, was distributed.
Nov 17, 2021Class IIB-0175-2022Platelets, Pathogen Reduced
Platelets, Pathogen Reduced, inappropriately prepared by recording the incorrect volume on label, were distributed.
Oct 6, 2020Class IIB-0068-2021Platelets, Pathogen Reduced
Platelet products, collected from donors who gave history which warranted deferral or follow up and was not deferred or follow up questions…
May 27, 2020Class IIB-0624-2020Red Blood Cells, Leukocytes Reduced, Irradiated and 1 more product
Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.
Jan 22, 2020Class IIIB-0316-2020Apheresis Platelets, Leukocytes Reduced
Plateletpheresis products for which monthly quality control for platelet yield testing was not performed, were distributed.
Jul 25, 2019Class IIB-0874-2019Red Blood Cells, Leukocytes Reduced, Irradiated and 1 more product
Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
Jun 27, 2019Class IIB-0760-2019Red Blood Cells, Leukocytes Reduced
Misbranded Leukoreduced Red Blood Cells were distributed.
Jan 4, 2019Class IIIB-0314-2019Apheresis Red Blood Cells, Leukocytes Reduced
Misbranded red blood cells were distributed.
Nov 6, 2018Class IIB-0214-2019Red Blood Cells, Leukocytes Reduced
Blood product, not meeting product specifications, was distributed.

FDA record score

16 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

39 records behind this number
RecordDatePoints x age weightAdds
Class II recall B-0293-2024, this FEI as the recalling firmMar 13, 20244 x 0.62.4
Class II recall B-0383-2023, this FEI as the recalling firmOct 7, 20224 x 0.62.4
Class II recall B-0175-2022, this FEI as the recalling firmNov 17, 20214 x 0.62.4
Class II recall B-0068-2021, this FEI as the recalling firmOct 6, 20204 x 0.251
Class II recall B-0624-2020, this FEI as the recalling firmMay 27, 20204 x 0.251
Class II recall B-0874-2019, this FEI as the recalling firmJul 25, 20194 x 0.251
Class II recall B-0760-2019, this FEI as the recalling firmJun 27, 20194 x 0.251
Class II recall B-0214-2019, this FEI as the recalling firmNov 6, 20184 x 0.251
Class II recall B-0291-2018, this FEI as the recalling firmNov 28, 20174 x 0.251
Class II recall B-0067-2018, this FEI as the recalling firmAug 8, 20174 x 0.251
Class II recall B-0721-2017, this FEI as the recalling firmJun 6, 20174 x 0.251
Class II recall B-0422-2017, this FEI as the recalling firmJan 3, 20174 x 0.251
Class II recall B-0045-2018, this FEI as the recalling firmAug 31, 201610 years or older, so it adds no points0
Class II recall B-0150-2017, this FEI as the recalling firmAug 26, 201610 years or older, so it adds no points0
Class II recall B-0381-16, this FEI as the recalling firmFeb 1, 201610 years or older, so it adds no points0
Class II recall B-0962-15, this FEI as the recalling firmJul 22, 201510 years or older, so it adds no points0
Class II recall B-0067-16, this FEI as the recalling firmMay 29, 201510 years or older, so it adds no points0
Inspection classified VAIMay 15, 201410 years or older, so it adds no points0
Class II recall B-0798-14, this FEI as the recalling firmApr 26, 201410 years or older, so it adds no points0
Class II recall B-0348-14, this FEI as the recalling firmNov 26, 201310 years or older, so it adds no points0
Class II recall B-0922-13, this FEI as the recalling firmDec 14, 201210 years or older, so it adds no points0
Inspection classified VAIMar 14, 201210 years or older, so it adds no points0
Inspection classified VAISep 27, 201010 years or older, so it adds no points0
Class II recall B-2034-08, this FEI as the recalling firmJan 11, 200810 years or older, so it adds no points0
Class II recall B-0915-08, this FEI as the recalling firmMar 28, 200610 years or older, so it adds no points0
Class II recall B-0769-08, this FEI as the recalling firmMay 27, 200510 years or older, so it adds no points0
Class II recall B-1344-07, this FEI as the recalling firmMay 20, 200510 years or older, so it adds no points0
Class II recall B-0757-08, this FEI as the recalling firmApr 29, 200510 years or older, so it adds no points0
Class II recall B-1766-6, this FEI as the recalling firmApr 19, 200510 years or older, so it adds no points0
Class II recall B-1705-6, this FEI as the recalling firmFeb 8, 200510 years or older, so it adds no points0
Class II recall B-1837-6, this FEI as the recalling firmJan 14, 200510 years or older, so it adds no points0
Class II recall B-1614-6, this FEI as the recalling firmOct 27, 200410 years or older, so it adds no points0
Class II recall B-1788-6, this FEI as the recalling firmOct 1, 200410 years or older, so it adds no points0
Class II recall B-1767-6, this FEI as the recalling firmSep 30, 200410 years or older, so it adds no points0
Class II recall B-0517-5, this FEI as the recalling firmNov 3, 200310 years or older, so it adds no points0
Class II recall B-0518-5, this FEI as the recalling firmMay 23, 200310 years or older, so it adds no points0
Class II recall B-0488-5, this FEI as the recalling firmApr 21, 200310 years or older, so it adds no points0
Class II recall B-0521-5, this FEI as the recalling firmMar 26, 200310 years or older, so it adds no points0
Class II recall B-0512-5, this FEI as the recalling firmDec 23, 200210 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Bergen Comm Reg Blood Center as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Bergen Comm Reg Blood Center yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Vitalant
Location
Montvale, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.